Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma-Reference-Cited by-同舟云学术

Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma

Published:2014-07-10 Issue:1 Volume:234 Page:23-33
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Campos Benito¹,Gal Zoltan¹,Baader Aline¹,Schneider Tilman¹,Sliwinski Christopher¹,Gassel Kristina¹,Bageritz Josephine²,Grabe Niels³,von Deimling Andreas⁴⁵,Beckhove Philipp⁶,Mogler Carolin⁷,Goidts Violaine²,Unterberg Andreas¹,Eckstein Volker⁸,Herold-Mende Christel¹

Affiliation:

1. Experimental Neurosurgery, Department of Neurosurgery; University of Heidelberg; INF 400 69120 Heidelberg Germany

2. Division of Molecular Genetics; German Cancer Research Center; INF 280 69120 Heidelberg Germany

3. Institute of Medical Biometry and Informatics, Hamamatsu Tissue Imaging and Analysis (TIGA) Center; University of Heidelberg; 69120 Heidelberg Germany

4. Department of Neuropathology, Institute of Pathology; University of Heidelberg; INF 220 69120 Heidelberg Germany

5. Clinical Cooperation Unit Neuropathology, German Cancer Center & Department of Neuropathology, Institute of Pathology; University of Heidelberg; 69120 Heidelberg Germany

6. Division of Tumour Immunology; German Cancer Research Center; INF 280 69120 Heidelberg Germany

7. Department of General Pathology; University of Heidelberg; INF 220 69120 Heidelberg Germany

8. Department of Medicine V; University of Heidelberg; INF 410 69120 Heidelberg Germany

Funder

Bundesministerium für Bildung und Forschung

Deutsche Krebshilfe

Familie-Mehdorn-Stiftung

Postdoc-Fellowship of the Medical Faculty of Heidelberg University

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4366/fullpdf

Reference29 articles.

1. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines;Lee;Cancer Cell,2006

2. Identification of human brain tumour initiating cells;Singh;Nature,2004

3. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors;Beier;Brain Pathol,2008

4. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme;Pallini;Clin Cancer Res,2008

5. Stem cell marker CD133 affects clinical outcome in glioma patients;Zeppernick;Clin Cancer Res,2008

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System;Cells;2024-05-29

2. Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?;Neuro-Oncology;2024-02-23

3. KR158 spheres harboring slow-cycling cells recapitulate GBM features in an immunocompetent system;2024-01-30

4. Advances in Glioma Stem Cell Research;Experts' Perspectives on Medical Advances;2024

5. Combining organotypic tissue culture with light‐sheet microscopy (OTCxLSFM) to study glioma invasion;EMBO reports;2023-11-08